Technion - Israel Institute of Technology

The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.

Researchers are developing a nanopore sensing device that relies on restriction enzymes to target specific clinically relevant variants in pathogens. 

Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.

The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus. 

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.